Advancements in T-cell Acute Lymphoblastic Leukemia and Innovative Therapies

This chapter explores recent innovations in treating T-cell acute lymphoblastic leukemia, emphasizing intensified pediatric protocols and risk stratification for better patient outcomes. It includes case studies on successful treatments, the role of chemotherapy agents, and discusses the emerging use of miRNA therapies and thrombopoietin receptor agonists.